Replimune Group, Inc.

NasdaqGS:REPL Rapporto sulle azioni

Cap. di mercato: US$682.5m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Replimune Group Gestione

Gestione criteri di controllo 3/4

Replimune Group's Il CEO è Sush Patel, nominato in Apr2024, e ha un mandato di meno di un anno. la retribuzione annua totale è $ 2.60M, composta da 17.2% di stipendio e 82.8% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.074% delle azioni della società, per un valore di $ 509.00K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 0.9 anni e 6.2 anni.

Informazioni chiave

Sush Patel

Amministratore delegato

US$2.6m

Compenso totale

Percentuale dello stipendio del CEO17.2%
Mandato del CEOless than a year
Proprietà del CEO0.07%
Durata media del managementless than a year
Durata media del Consiglio di amministrazione6.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?

Aug 16
Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?

Replimune: Continuing To Justify The Bear Thesis (For Now)

May 22

Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Feb 06
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Replimune: The Fall Is Justified, As Virus Therapy Fails Again In Cancer

Jan 23

Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)

Dec 25
Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)

Is Replimune Group (NASDAQ:REPL) A Risky Investment?

Jul 13
Is Replimune Group (NASDAQ:REPL) A Risky Investment?

Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?

Apr 05
Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?

A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)

Jan 06
A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)

Replimune secures $200M term loan

Oct 07

Replimune: Recent Developments Strengthen Bull Thesis

Aug 12

Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Aug 06
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Replimune Group GAAP EPS of -$0.78 misses by $0.15

Aug 04

Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate

Jun 24
Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate

We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate

Apr 04
We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate

Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth

Dec 16
Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth

Replimune: In The 'Buy Zone' Again

Oct 01

Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)

Sep 02
Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)

Replimune Group (NASDAQ:REPL) Is In A Strong Position To Grow Its Business

May 24
Replimune Group (NASDAQ:REPL) Is In A Strong Position To Grow Its Business

Replimune: Oncolytic Immunotherapy Pioneer Gaining Momentum In The Clinic

Apr 30

We're Interested To See How Replimune Group (NASDAQ:REPL) Uses Its Cash Hoard To Grow

Feb 08
We're Interested To See How Replimune Group (NASDAQ:REPL) Uses Its Cash Hoard To Grow

Replimune Group EPS misses by $0.03

Feb 04

Dosing underway in Replimune's early-stage cancer study with gene therapy

Jan 05

Replimune: Interesting Developer Of Oncolytic Immunotherapies

Dec 06

Replimune Group EPS misses by $0.02

Nov 05

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Sush Patel rispetto agli utili di Replimune Group?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-US$220m

Mar 31 2024n/an/a

-US$216m

Dec 31 2023n/an/a

-US$210m

Sep 30 2023n/an/a

-US$199m

Jun 30 2023n/an/a

-US$182m

Mar 31 2023US$3mUS$447k

-US$174m

Dec 31 2022n/an/a

-US$157m

Sep 30 2022n/an/a

-US$147m

Jun 30 2022n/an/a

-US$133m

Mar 31 2022US$7mUS$394k

-US$118m

Compensazione vs Mercato: La retribuzione totale di Sush ($USD 2.60M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 3.30M ).

Compensazione vs guadagni: La retribuzione di Sush è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Sush Patel (53 yo)

less than a year

Mandato

US$2,595,003

Compensazione

Dr. Sushil Patel, also known as Sush,Ph D, is CEO & Director of Replimune Group, Inc. from April 1, 2024. Dr. Patel served as the Chief Commercial Officer at Replimune Group, Inc. since May 3, 2021 and ser...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Philip Astley-Sparke
Executive Chairman9.6yrsUS$6.02m1.94%
$ 13.2m
Emily Hill
Chief Financial Officerless than a yearUS$3.61m0.017%
$ 118.8k
Konstantinos Xynos
Chief Medical Officer1.7yrsUS$2.45m0.017%
$ 113.3k
Sushil Patel
CEO & Directorless than a yearUS$2.60m0.074%
$ 503.0k
Robert Coffin
Founderno dataUS$5.72m2.57%
$ 17.5m
Andrew Schwendenman
Chief Accounting Officer & Treasurer1.3yrsNessun dato0.010%
$ 70.1k
Christopher Sarchi
Chief Commercial Officer1.7yrsNessun dato0.017%
$ 118.9k
Paul Bullock
Chief Manufacturing Officer & Framingham Site Headless than a yearNessun datoNessun dato

0.9yrs

Durata media

53yo

Età media

Gestione esperta: Il team dirigenziale di REPL non è considerato esperto (durata media 0.9 anni), il che suggerisce un nuovo team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Philip Astley-Sparke
Executive Chairman9.6yrsUS$6.02m1.94%
$ 13.2m
Sushil Patel
CEO & Directorless than a yearUS$2.60m0.074%
$ 503.0k
Robert Coffin
Founder9.6yrsUS$5.72m2.57%
$ 17.5m
Joseph Slattery
Independent Director6.8yrsUS$362.60k0.0098%
$ 66.6k
Hyam Levitsky
Independent Non-Executive Director6.3yrsUS$355.10k0%
$ 0
Paolo Pucci
Independent Director4.3yrsUS$360.10k0%
$ 0
Kapil Dhingra
Independent Director7.1yrsUS$357.60k0%
$ 0
Christy Oliger
Independent Director2.7yrsUS$352.60k0%
$ 0
Dieter Weinand
Lead Independent Director6.2yrsUS$516.81k0%
$ 0
Veleka Peeples-Dyer
Independent Director1.2yrsUS$667.97k0%
$ 0

6.2yrs

Durata media

59yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di REPL sono considerati esperti (durata media dell'incarico 6.2 anni).